TY - JOUR AU - Staab, D. PY - 2004 DA - 2004// TI - Cystic fibrosis - therapeutic challenge in cystic fibrosis children JO - Eur J Endocrinol VL - 151 UR - https://doi.org/10.1530/eje.0.151S077 DO - 10.1530/eje.0.151S077 ID - Staab2004 ER - TY - JOUR AU - Baltimore, R. S. AU - Christie, C. D. AU - Smith, G. J. PY - 1989 DA - 1989// TI - Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration JO - Am Rev Respir Dis VL - 140 UR - https://doi.org/10.1164/ajrccm/140.6.1650 DO - 10.1164/ajrccm/140.6.1650 ID - Baltimore1989 ER - TY - JOUR AU - Costerton, J. W. AU - Cheng, K. J. AU - Geesey, G. G. AU - Ladd, T. I. AU - Nickel, J. C. AU - Dasgupta, M. AU - Marrie, T. J. PY - 1987 DA - 1987// TI - Bacterial biofilms in nature and disease JO - Annu Rev Microbiol VL - 41 UR - https://doi.org/10.1146/annurev.mi.41.100187.002251 DO - 10.1146/annurev.mi.41.100187.002251 ID - Costerton1987 ER - TY - JOUR AU - Drenkard, E. AU - Ausubel, F. M. PY - 2002 DA - 2002// TI - Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation JO - Nature VL - 416 UR - https://doi.org/10.1038/416740a DO - 10.1038/416740a ID - Drenkard2002 ER - TY - JOUR AU - Singh, P. K. AU - Schaefer, A. L. AU - Parsek, M. R. AU - Moninger, T. O. AU - Welsh, M. J. AU - Greenberg, E. P. PY - 2000 DA - 2000// TI - Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms JO - Nature VL - 407 UR - https://doi.org/10.1038/35037627 DO - 10.1038/35037627 ID - Singh2000 ER - TY - JOUR AU - Hacth, R. A. AU - Schiller, N. L. PY - 1998 DA - 1998// TI - Alginate lyase promotes diffusion of aminoglycosides through the extracellular polysaccharide of mucoid Pseudomonas aeruginosa JO - Antimicrob Agents Chemother VL - 42 ID - Hacth1998 ER - TY - JOUR AU - Costerton, J. W. AU - Stewart, P. S. AU - Greenberg, E. P. PY - 1999 DA - 1999// TI - Bacterial biofilms: a common cause of persistent infections JO - Science VL - 284 UR - https://doi.org/10.1126/science.284.5418.1318 DO - 10.1126/science.284.5418.1318 ID - Costerton1999 ER - TY - JOUR AU - Rogers, G. B. AU - Hoffman, L. R. AU - Whiteley, M. AU - Daniels, T. W. AU - Carroll, M. P. AU - Bruce, K. D. PY - 2010 DA - 2010// TI - Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy JO - Trends Microbiol VL - 18 UR - https://doi.org/10.1016/j.tim.2010.04.005 DO - 10.1016/j.tim.2010.04.005 ID - Rogers2010 ER - TY - JOUR AU - Lopez-Boado, Y. S. AU - Rubin, B. K. PY - 2008 DA - 2008// TI - Macrolides as immunomodulatory medications for the therapy of chronic lung diseases JO - Curr Opin Pharmacol VL - 8 UR - https://doi.org/10.1016/j.coph.2008.01.010 DO - 10.1016/j.coph.2008.01.010 ID - Lopez-Boado2008 ER - TY - JOUR AU - Schoni, M. H. PY - 2003 DA - 2003// TI - Macrolide antibiotic therapy in patients with cystic fibrosis JO - Swiss Med Wkly VL - 133 ID - Schoni2003 ER - TY - JOUR AU - Nguyen, T. AU - Louie, S. G. AU - Beringer, P. M. AU - Gill, M. A. PY - 2002 DA - 2002// TI - Potential role of macrolide antibiotics in the management of cystic fibrosis lung disease JO - Curr Opin Pulm Med VL - 8 UR - https://doi.org/10.1097/00063198-200211000-00007 DO - 10.1097/00063198-200211000-00007 ID - Nguyen2002 ER - TY - JOUR AU - Shinkai, M. AU - Foster, G. H. AU - Rubin, B. K. PY - 2006 DA - 2006// TI - Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells JO - Am J Physiol Lung Cell Mol Physiol VL - 290 UR - https://doi.org/10.1152/ajplung.00093.2005 DO - 10.1152/ajplung.00093.2005 ID - Shinkai2006 ER - TY - JOUR AU - Shinkai, M. AU - Lopez-Boado, Y. S. AU - Rubin, B. K. PY - 2007 DA - 2007// TI - Clarithromycin has an immunomodulatory effect on ERK-mediated inflammation induced by Pseudomonas aeruginosa flagellin JO - J Antimicrob Chemother VL - 59 UR - https://doi.org/10.1093/jac/dkm084 DO - 10.1093/jac/dkm084 ID - Shinkai2007 ER - TY - JOUR AU - Shinkai, M. AU - Tamaoki, J. AU - Kobayashi, H. AU - Kanoh, S. AU - Motoyoshi, K. AU - Kute, T. AU - Rubin, B. K. PY - 2006 DA - 2006// TI - Clarithromycin delays progression of bronchial epithelial cells from G1 phase to S phase and delays cell growth via extracellular signal-regulated protein kinase suppression JO - Antimicrob Agents Chemother VL - 50 UR - https://doi.org/10.1128/AAC.50.5.1738-1744.2006 DO - 10.1128/AAC.50.5.1738-1744.2006 ID - Shinkai2006 ER - TY - JOUR AU - Parnham, M. J. PY - 2005 DA - 2005// TI - Immunomodulatory effects of antimicrobials in the therapy of respiratory tract infections JO - Curr Opin Infect Dis VL - 18 UR - https://doi.org/10.1097/01.qco.0000160901.71813.fe DO - 10.1097/01.qco.0000160901.71813.fe ID - Parnham2005 ER - TY - JOUR AU - Culic, O. AU - Erakovic, V. AU - Parnham, M. J. PY - 2001 DA - 2001// TI - Anti-inflammatory effects of macrolide antibiotics JO - Eur J Pharmacol VL - 429 UR - https://doi.org/10.1016/S0014-2999(01)01321-8 DO - 10.1016/S0014-2999(01)01321-8 ID - Culic2001 ER - TY - JOUR AU - Schultz, M. J. PY - 2004 DA - 2004// TI - Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis JO - J Antimicrob Chemother VL - 54 UR - https://doi.org/10.1093/jac/dkh309 DO - 10.1093/jac/dkh309 ID - Schultz2004 ER - TY - JOUR AU - Fujimura, S. AU - Sato, T. AU - Kikuchi, T. AU - Gomi, K. AU - Watanabe, A. AU - Mchami, T. PY - 2008 DA - 2008// TI - Combined efficacy of clarithromycin plus cefazolin or vancomycin against Staphylococcus aureus biofilms formed on titanium medical devices JO - Int J Antimicrob Agents VL - 32 UR - https://doi.org/10.1016/j.ijantimicag.2008.06.030 DO - 10.1016/j.ijantimicag.2008.06.030 ID - Fujimura2008 ER - TY - JOUR AU - Moskowitz, S. M. AU - Foster, J. M. AU - Emerson, J. AU - Burns, J. L. PY - 2004 DA - 2004// TI - Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis JO - J Clin Microbiol VL - 42 UR - https://doi.org/10.1128/JCM.42.5.1915-1922.2004 DO - 10.1128/JCM.42.5.1915-1922.2004 ID - Moskowitz2004 ER - TY - JOUR AU - Soboh, F. AU - Khoury, A. E. AU - Zamboni, A. C. AU - Davidson, D. AU - Mittelman, M. W. PY - 1995 DA - 1995// TI - Effects of ciprofloxacin and protamine sulfate combinations against catheter-associated Pseudomonas aeruginosa biofilms JO - Antimicrob Agents Chemother VL - 39 UR - https://doi.org/10.1128/AAC.39.6.1281 DO - 10.1128/AAC.39.6.1281 ID - Soboh1995 ER - TY - JOUR AU - Gander, S. AU - Gilbert, P. PY - 2010 DA - 2010// TI - The development of a small-scale biofilm model suitable for studying the effects of antibiotics on biofilms of gram-negative bacteria JO - J Antirnicrob Chernother VL - 40 UR - https://doi.org/10.1093/jac/40.3.329 DO - 10.1093/jac/40.3.329 ID - Gander2010 ER - TY - JOUR AU - Dasugupta, M. K. AU - Shishida, H. AU - Salama, S. AU - Singh, R. AU - Larabie, M. AU - Micetich, R. G. PY - 1997 DA - 1997// TI - The effect of macrolide and quinolone antibiotics in methicillin-resistant Staphylococcus aureus biofilm growth JO - Ad Perit Dial VL - 13 ID - Dasugupta1997 ER - TY - JOUR AU - Tre-Hardy, M. AU - Nagant, C. AU - El, M. N. AU - Vanderbist, F. AU - Traore, H. AU - Vaneechoutte, M. AU - Dehaye, J. P. PY - 2010 DA - 2010// TI - Efficacy of the combination of tobramycin and a macrolide in an in vitro Pseudomonas aeruginosa mature biofilm model JO - Antimicrob Agents Chemother VL - 54 UR - https://doi.org/10.1128/AAC.00372-10 DO - 10.1128/AAC.00372-10 ID - Tre-Hardy2010 ER - TY - JOUR AU - Tre-Hardy, M. AU - Vanderbist, F. AU - Traore, H. AU - Devleeschouwer, M. J. PY - 2008 DA - 2008// TI - In vitro activity of antibiotic combinations against Pseudomonas aeruginosa Biofilm and planktonic cultures JO - Int J Antimicrob Agents VL - 31 UR - https://doi.org/10.1016/j.ijantimicag.2007.12.005 DO - 10.1016/j.ijantimicag.2007.12.005 ID - Tre-Hardy2008 ER - TY - JOUR AU - Cirioni, O. AU - Ghiselli, R. AU - Silvestri, C. AU - Minardi, D. AU - Gabrielli, E. AU - Orlando, F. AU - Rimini, M. AU - Brescini, L. AU - Muzzonigro, G. AU - Guerrieri, M. AU - Giacometti, A. PY - 2011 DA - 2011// TI - Effect of the combination of clarithromycin and amikacin on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection JO - J Antimicrob Chemother VL - 66 UR - https://doi.org/10.1093/jac/dkr107 DO - 10.1093/jac/dkr107 ID - Cirioni2011 ER - TY - JOUR AU - Bala, A. AU - Kumar, R. AU - Harjai, K. PY - 2011 DA - 2011// TI - Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections JO - J Med Microbiol VL - 60 UR - https://doi.org/10.1099/jmm.0.025387-0 DO - 10.1099/jmm.0.025387-0 ID - Bala2011 ER - TY - JOUR AU - Gillis, R. J. AU - Iglewski, B. H. PY - 2004 DA - 2004// TI - Azithromycin retards Pseudomonas aeruginosa Biofilm formation JO - J Clin Microbiol VL - 42 UR - https://doi.org/10.1128/JCM.42.12.5842-5845.2004 DO - 10.1128/JCM.42.12.5842-5845.2004 ID - Gillis2004 ER - TY - JOUR AU - Tateda, K. AU - Comte, R. AU - Pechere, J. C. AU - Kohler, T. AU - Yamaguchi, K. AU - Van, D. C. PY - 2001 DA - 2001// TI - Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa JO - Antimicrob Agents Chemother VL - 45 UR - https://doi.org/10.1128/AAC.45.6.1930-1933.2001 DO - 10.1128/AAC.45.6.1930-1933.2001 ID - Tateda2001 ER - TY - JOUR AU - Equi, A. AU - Balfour-Lynn, I. M. AU - Bush, A. AU - Rosenthal, M. PY - 2002 DA - 2002// TI - Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial JO - Lancet VL - 360 UR - https://doi.org/10.1016/S0140-6736(02)11081-6 DO - 10.1016/S0140-6736(02)11081-6 ID - Equi2002 ER - TY - JOUR AU - Wolter, J. AU - Seeney, S. AU - Bell, S. AU - Bowler, S. AU - Masel, P. AU - McCormack, J. PY - 2002 DA - 2002// TI - Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial JO - Thorax VL - 57 UR - https://doi.org/10.1136/thorax.57.3.212 DO - 10.1136/thorax.57.3.212 ID - Wolter2002 ER - TY - JOUR AU - Saiman, L. AU - Chen, Y. AU - Gabriel, P. S. AU - Knirsch, C. PY - 2002 DA - 2002// TI - Synergistic activities of macrolide antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans isolated from patients with cystic fibrosis JO - Antimicrob Agents Chemother VL - 46 UR - https://doi.org/10.1128/AAC.46.4.1105-1107.2002 DO - 10.1128/AAC.46.4.1105-1107.2002 ID - Saiman2002 ER - TY - BOOK AU - Murray, P. R. AU - Baron, E. J. AU - Jorgensen, J. H. AU - Pfaller, M. A. AU - Yolken, R. H. PY - 2003 DA - 2003// TI - Manual of clinical microbiology PB - ASM Press CY - Washington ID - Murray2003 ER - TY - BOOK PY - 2009 DA - 2009// TI - Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically M07-A8 PB - CLSI CY - Wayne ID - ref33 ER - TY - BOOK PY - 2010 DA - 2010// TI - Performance Standards for antimicrobial susceptibility testing. M100-S20 PB - CLSI CY - Wayne ID - ref34 ER - TY - JOUR AU - Ichimiya, T. AU - Yamasaki, T. AU - Nasu, M. PY - 1994 DA - 1994// TI - In vitro effects of antimicrobial agents on Pseudomonas aeruginosa Biofilm formation JO - J Antimicrob Chemother VL - 34 UR - https://doi.org/10.1093/jac/34.3.331 DO - 10.1093/jac/34.3.331 ID - Ichimiya1994 ER - TY - JOUR AU - Moskowitz, S. M. AU - Foster, J. M. AU - Emerson, J. C. AU - Gibson, R. L. AU - Burns, J. L. PY - 2005 DA - 2005// TI - Use of Pseudomonas Biofilm susceptibilities to assign simulated antibiotic regimens for cystic fibrosis airway infection JO - J Antimicrob Chemother VL - 56 UR - https://doi.org/10.1093/jac/dki338 DO - 10.1093/jac/dki338 ID - Moskowitz2005 ER -